Publications

5674 Results

Response to induction chemotherapy does not predict for long term survival among patients with unresected stage III non-small cell lung cancer (NSCLC) receiving sequential chemo-radiation on RTOG 8804 and 8808.

Authors
WJ Curran;CB Scott;R Komaki;RW Byhardt;S Taylor;B Emami;CJ Langer;AR Dar;JS Cooper;EJ Andras;WT Sause
Journal / Conference
Int.l Journal of Radiation Oncology Biology Physics 32Suppl:196(#111)
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group study

Authors
CJ Fabian;CM Mansfield;S Dahlberg;SE Jones;TP Miller;E Van Slyck;PN Grozea;FS Morrison;CA Coltman, Jr;RI Fisher
Journal / Conference
Annals of Internal Medicine 120(11):903-912
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7808

Phase II trial of menogaril in metastatic adenocarcinoma of the prostate: A Southwest Oncology Group study.

Authors
SA Taylor;BA Blumenstein;RL Stephens;ED Crawford;B Pistone;JB Hill
Journal / Conference
Investigational New Drugs 12:67-70
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8509

A phase II evaluation of amonafide in advanced sarcoma: A Southwest Oncology Group study.

Authors
SS Buys;B Metch;SP Balcerzak;JR Neefe;WJ Stuckey
Journal / Conference
Cancer Investigation 12(4):399-402
Year
1994
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8715

Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: A Southwest Oncology Group study.

Authors
R Saez;S Dahlberg;FR Appelbaum;RJ Hartsock;F LeMaistre;CA Coltman Jr.;RI Fisher
Journal / Conference
Hematological Oncology 12(2):75-85
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8309

Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors: A Southwest Oncology Group study

Authors
V Gupta;EB Thompson;D Stock-Novack;SE Salmon;HI Pierce;JD Bonnet;D Chilton;J Beckord
Journal / Conference
Investigational New Drugs 12(2):121-128
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8530

Chemotherapy as predictor of compliance.

Authors
JR Jacobs;RR Casiano;DE Schuller;TF Pajak;GE Laramore;M Al-Sarraf
Journal / Conference
Journal of Surgical Oncology 55:143-148
Year
1994
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

The effect of perioperative blood transfusion on survival in head and neck cancer.

Authors
DE Schuller;C Scott;KM Wilson;R Freer;M Al-Sarraf;J Jacobs;K Ahmad;R Casiano;G Laramore
Journal / Conference
Archives of Otolaryngology-Head and Neck Surgery 120:711-716
Year
1994
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer: A Southwest Oncology Group study.

Authors
JO Atiba;SJ Green;HE Hynes;CK Osborne;TP Miller;M Davidner
Journal / Conference
Investigational New Drugs 12:129-132
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-8608

Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.

Authors
ME Marshall;B Blumenstein;ED Crawford;IM Thompson;JB Craig;M Eisenberger;F Ahmann
Journal / Conference
American Journal of Clinical Oncology 17(6):514-515
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8722